🔎 Trials Near Me

Home › Familial Amyloid Neuropathies › California

Pag-aaral pangklinika para sa Familial Amyloid Neuropathies sa California

5 pag-aaral para sa Familial Amyloid Neuropathies ang naghahanap ng mga kalahok sa mga site sa California.

Mga Lungsod sa California

Opisyal na teksto ng pag-aaral (English)

Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis

  • Research Site, La Jolla
  • Research Site, Los Angeles
  • Research Site, San Francisco
  • at 1 pa
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT06465810

ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)

  • Clinical Trial Site, La Jolla
  • Clinical Trial Site, Los Angeles
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Set 8, 2026 · NCT04561518

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

  • University of California, San Diego (UCSD) - Medical Center, La Jolla
  • University of California, Los Angeles (UCLA) - David Geffen School of Medicine, Los Angeles
  • University of California, San Francisco (UCSF), San Francisco
  • at 1 pa
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT06563895

Artificial Intelligence Guided Echocardiographic Screening of Rare Diseases (EchoNet-Screening)

  • Cedars-Sinai Medical Centre (Los Angeles), Los Angeles
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT05139797

Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis

  • Cedars-Sinai Medical Center, Beverly Hills
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 50 pataas · Lahat ng kasarian · Na-update Hun 4, 2026 · NCT06034405

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.